Search

Your search keyword '"Villamor, Neus"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Villamor, Neus" Remove constraint Author: "Villamor, Neus" Publisher wiley Remove constraint Publisher: wiley
38 results on '"Villamor, Neus"'

Search Results

1. A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma

2. Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia

3. First external validation of the FLIPI‐L score in a single‐centre series of patients with follicular lymphoma

4. Clinico‐biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation

5. Prognostic ability of five clinical risk scores in follicular lymphoma: A single‐center evaluation

6. The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients

7. Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma

9. Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia

10. Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era

11. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project

12. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project

13. Is there a role for minimal residual disease monitoring in the management of patients with hairy-cell leukaemia?

14. CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutatedIGHVstatus

15. Detection of chromothripsis‐like patterns with a custom array platform for chronic lymphocytic leukemia

16. Clonal evolution in chronic lymphocytic leukemia: Analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance

17. NOTCH1 mutations in chronic lymphocytic leukemia with trisomy 12

18. Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations

19. A new genetic abnormality leading to TP53 gene deletion in chronic lymphocytic leukaemia

20. Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma

23. Leukemic involvement is a common feature in mantle cell lymphoma

24. Evaluation of ZAP‐70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process

26. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients

28. Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms

29. Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation

31. Inhibition of 5‐lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis

38. Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL.

Catalog

Books, media, physical & digital resources